Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.

Kundu K, Ghosh S, Sarkar R, Edri A, Brusilovsky M, Gershoni-Yahalom O, Yossef R, Shemesh A, Soria JC, Lazar V, Joshua BZ, Campbell KS, Elkabets M, Porgador A.

Cancer Immunol Res. 2019 Jul;7(7):1120-1134. doi: 10.1158/2326-6066.CIR-19-0023. Epub 2019 Jun 4.


Genetic, Inflammatory, and Epithelial Cell Differentiation Factors Control Expression of Human Calpain-14.

Miller DE, Forney C, Rochman M, Cranert S, Habel J, Rymer J, Lynch A, Schroeder C, Lee J, Sauder A, Smith Q, Chawla M, Trimarchi MP, Lu X, Fjellman E, Brusilovsky M, Barski A, Waggoner S, Weirauch MT, Rothenberg ME, Kottyan LC.

G3 (Bethesda). 2019 Mar 7;9(3):729-736. doi: 10.1534/g3.118.200901.


Chromatin regulates IL-33 release and extracellular cytokine activity.

Travers J, Rochman M, Miracle CE, Habel JE, Brusilovsky M, Caldwell JM, Rymer JK, Rothenberg ME.

Nat Commun. 2018 Aug 14;9(1):3244. doi: 10.1038/s41467-018-05485-x.


The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells.

Edri A, Shemesh A, Iraqi M, Matalon O, Brusilovsky M, Hadad U, Radinsky O, Gershoni-Yahalom O, Dye JM, Mandelboim O, Barda-Saad M, Lobel L, Porgador A.

Front Immunol. 2018 Jul 2;9:1428. doi: 10.3389/fimmu.2018.01428. eCollection 2018.


Splice variants of human natural cytotoxicity receptors: novel innate immune checkpoints.

Shemesh A, Brusilovsky M, Kundu K, Ottolenghi A, Campbell KS, Porgador A.

Cancer Immunol Immunother. 2018 Dec;67(12):1871-1883. doi: 10.1007/s00262-017-2104-x. Epub 2017 Dec 20. Review.


Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind FcγRI.

Radinsky O, Edri A, Brusilovsky M, Fedida-Metula S, Sobarzo A, Gershoni-Yahalom O, Lutwama J, Dye J, Lobel L, Porgador A.

Sci Rep. 2017 Jul 20;7(1):6054. doi: 10.1038/s41598-017-06226-8.


Regulation of the Functions of Natural Cytotoxicity Receptors by Interactions with Diverse Ligands and Alterations in Splice Variant Expression.

Pazina T, Shemesh A, Brusilovsky M, Porgador A, Campbell KS.

Front Immunol. 2017 Mar 30;8:369. doi: 10.3389/fimmu.2017.00369. eCollection 2017. Review.


Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity.

Shemer-Avni Y, Kundu K, Shemesh A, Brusilovsky M, Yossef R, Meshesha M, Solomon-Alemayehu S, Levin S, Gershoni-Yahalom O, Campbell KS, Porgador A.

Front Immunol. 2017 Feb 15;8:161. doi: 10.3389/fimmu.2017.00161. eCollection 2017.


Survival in acute myeloid leukemia is associated with NKp44 splice variants.

Shemesh A, Brusilovsky M, Hadad U, Teltsh O, Edri A, Rubin E, Campbell KS, Rosental B, Porgador A.

Oncotarget. 2016 May 31;7(22):32933-45. doi: 10.18632/oncotarget.8782.


First Trimester Pregnancy Loss and the Expression of Alternatively Spliced NKp30 Isoforms in Maternal Blood and Placental Tissue.

Shemesh A, Tirosh D, Sheiner E, Tirosh NB, Brusilovsky M, Segev R, Rosental B, Porgador A.

Front Immunol. 2015 Jun 1;6:189. doi: 10.3389/fimmu.2015.00189. eCollection 2015.


Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.

Brusilovsky M, Radinsky O, Cohen L, Yossef R, Shemesh A, Braiman A, Mandelboim O, Campbell KS, Porgador A.

Eur J Immunol. 2015 Apr;45(4):1180-91. doi: 10.1002/eji.201445177. Epub 2015 Jan 21.


Carbohydrate-mediated modulation of NK cell receptor function: structural and functional influences of heparan sulfate moieties expressed on NK cell surface.

Brusilovsky M, Radinsky O, Yossef R, Campbell KS, Porgador A.

Front Oncol. 2014 Jul 16;4:185. doi: 10.3389/fonc.2014.00185. eCollection 2014. Review. No abstract available.


Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.

Brusilovsky M, Cordoba M, Rosental B, Hershkovitz O, Andrake MD, Pecherskaya A, Einarson MB, Zhou Y, Braiman A, Campbell KS, Porgador A.

J Immunol. 2013 Nov 15;191(10):5256-67. doi: 10.4049/jimmunol.1302079. Epub 2013 Oct 14.


A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.

Rosental B, Hadad U, Brusilovsky M, Campbell KS, Porgador A.

Oncoimmunology. 2012 Jul 1;1(4):572-574.


Human NK cell recognition of target cells in the prism of natural cytotoxicity receptors and their ligands.

Brusilovsky M, Rosental B, Shemesh A, Appel MY, Porgador A.

J Immunotoxicol. 2012 Jul-Sep;9(3):267-74. doi: 10.3109/1547691X.2012.675366. Epub 2012 Apr 23. Review.


The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.

Rosental B, Appel MY, Yossef R, Hadad U, Brusilovsky M, Porgador A.

Curr Med Chem. 2012;19(12):1780-91. Review.


Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.

Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, Afergan F, Yossef R, Rosenberg LA, Aharoni A, Cerwenka A, Campbell KS, Braiman A, Porgador A.

J Immunol. 2011 Dec 1;187(11):5693-702. doi: 10.4049/jimmunol.1102267. Epub 2011 Oct 21.

Supplemental Content

Loading ...
Support Center